• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非囊性纤维化性支气管扩张症。

Non-cystic fibrosis bronchiectasis.

机构信息

Department of Respiratory Medicine, Galway University Hospitals, Newcastle Road, Galway, Ireland.

出版信息

QJM. 2013 Aug;106(8):709-15. doi: 10.1093/qjmed/hct109. Epub 2013 May 30.

DOI:10.1093/qjmed/hct109
PMID:23728208
Abstract

Bronchiectasis is a chronic debilitating condition with considerable phenotypic diversity. A vicious cycle of infection and inflammation exists in damaged airways with patients suffering from persistent cough, purulent sputum production, recurrent chest infections and general malaise. The associated burden of disease in terms of increased morbidity, reduced quality of life and the socioeconomic cost of long-term management is significant. Further research is essential to improve our understanding of the development and progression of this disease. This article reviews what is currently known about bronchiectasis, its pathophysiology, aetiology and management strategies.

摘要

支气管扩张症是一种慢性消耗性疾病,具有相当大的表型多样性。在受损的气道中存在感染和炎症的恶性循环,患者会持续咳嗽、咳出脓性痰、反复发生胸部感染和全身不适。该病的疾病负担增加,包括发病率升高、生活质量下降以及长期管理的社会经济成本,这是非常显著的。进一步的研究对于提高我们对这种疾病的发展和进展的理解至关重要。本文综述了目前对支气管扩张症的认识,包括其病理生理学、病因学和管理策略。

相似文献

1
Non-cystic fibrosis bronchiectasis.非囊性纤维化性支气管扩张症。
QJM. 2013 Aug;106(8):709-15. doi: 10.1093/qjmed/hct109. Epub 2013 May 30.
2
Non-cystic fibrosis bronchiectasis.非囊性纤维化性支气管扩张症。
Am J Respir Crit Care Med. 2013 Sep 15;188(6):647-56. doi: 10.1164/rccm.201303-0411CI.
3
Non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症
J R Coll Physicians Edinb. 2011 Jun;41(2):132-9; quiz 139. doi: 10.4997/JRCPE.2011.217.
4
Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?吸入性糖皮质激素和大环内酯类药物疗法在支气管扩张症中起作用吗?
Drugs. 2007;67(7):965-74. doi: 10.2165/00003495-200767070-00002.
5
Update in Bronchiectasis 2014.2014年支气管扩张症最新进展
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1155-61. doi: 10.1164/rccm.201505-0926UP.
6
Bronchiectasis: new approaches to diagnosis and management.支气管扩张症:新的诊断和治疗方法。
Clin Chest Med. 2011 Sep;32(3):535-46. doi: 10.1016/j.ccm.2011.05.002.
7
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.
8
Interventions for bronchiectasis: an overview of Cochrane systematic reviews.支气管扩张症的干预措施:Cochrane系统评价概述
Cochrane Database Syst Rev. 2015 Jul 14;2015(7):CD010337. doi: 10.1002/14651858.CD010337.pub2.
9
Bronchiectasis.支气管扩张症。
Nat Rev Dis Primers. 2018 Nov 15;4(1):45. doi: 10.1038/s41572-018-0042-3.
10
Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century.非囊性纤维化性支气管扩张症:21 世纪的诊断与管理。
Postgrad Med J. 2010 Aug;86(1018):493-501. doi: 10.1136/pgmj.2009.091041.

引用本文的文献

1
Non-cystic fibrosis bronchiectasis: A single-centre retrospective study in Johannesburg, South Africa.非囊性纤维化支气管扩张症:南非约翰内斯堡的一项单中心回顾性研究。
Afr J Thorac Crit Care Med. 2023 Nov 27;29(4):e1017. doi: 10.7196/AJTCCM.2023.v29i4.1017. eCollection 2023.
2
Efficacy and safety of macrolides in the treatment of children with bronchiectasis: a meta-analysis.大环内酯类药物治疗儿童支气管扩张症的疗效与安全性:一项荟萃分析
Pediatr Res. 2023 Nov;94(5):1600-1608. doi: 10.1038/s41390-023-02591-5. Epub 2023 May 26.
3
Poor outcomes in recurrent tuberculosis: More than just drug resistance?
复发性结核病结局较差:不仅仅是耐药问题?
PLoS One. 2019 May 6;14(5):e0215855. doi: 10.1371/journal.pone.0215855. eCollection 2019.
4
Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis.大环内酯类药物维持治疗预防非囊性纤维化支气管扩张症患者疾病加重的荟萃分析。
Medicine (Baltimore). 2019 Apr;98(17):e15285. doi: 10.1097/MD.0000000000015285.
5
The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation.原发性免疫缺陷中的肺部疾病:感染与炎症的新概念。
Front Immunol. 2018 Aug 8;9:1837. doi: 10.3389/fimmu.2018.01837. eCollection 2018.
6
Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013.2013 年美国成年人非囊性纤维化支气管扩张症的患病率和发病率。
Chron Respir Dis. 2017 Nov;14(4):377-384. doi: 10.1177/1479972317709649. Epub 2017 May 30.
7
Two cases of non-cystic fibrosis (CF) bronchiectasis with allergic bronchopulmonary aspergillosis.两例非囊性纤维化(CF)支气管扩张合并变应性支气管肺曲霉病。
Respir Med Case Rep. 2016 Dec 19;20:68-71. doi: 10.1016/j.rmcr.2016.12.005. eCollection 2017.
8
'"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection.“为什么是我,为什么是现在?”运用临床免疫学和流行病学来解释谁会感染非结核分枝杆菌。
BMC Med. 2016 Mar 23;14:54. doi: 10.1186/s12916-016-0606-6.
9
Bacterial colonization and associated factors in patients with bronchiectasis.支气管扩张症患者的细菌定植及相关因素
Ann Thorac Med. 2016 Jan-Mar;11(1):55-9. doi: 10.4103/1817-1737.172297.
10
Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials.大环内酯类药物长期应用于非囊性纤维化支气管扩张症患者的疗效:一项随机对照试验的荟萃分析
BMC Infect Dis. 2015 Mar 27;15:160. doi: 10.1186/s12879-015-0872-5.